hims fda warning letter compounded semaglutide 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Super Bowl ad from Hims

Zepbound (tirzepatide) is a dual GIP and GLP-1 receptor agonist that mimics the action of two hormones in the body, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1)

Last September, Jenn Rossum hit a wall

Members of this program can connect with third-party prescribers (for an appointment) and have prescriptions filled via Walmart pharmacies with fast delivery (as quick as 1 hour) ( [59] )

Caloric floor and protein minimums Regardless of how aggressively your GLP-1 medication suppresses appetite, you must maintain adequate nutrition

He represents TruGen3 and can be contacted at drmeletis.com

It is an investigational triple hormone receptor agonist